These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 18261836)
1. Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library. Dander E; Li Pira G; Biagi E; Perseghin P; Renoldi G; Gaipa G; Introna M; Marin V; Manca F; Biondi A; D'Amico G Exp Hematol; 2008 Apr; 36(4):473-85. PubMed ID: 18261836 [TBL] [Abstract][Full Text] [Related]
2. Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution. Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Del Galdo F; Lozzi L; Bracci L; Loregian A; Palù G; De Palma R; Einsele H; Manca F Int Immunol; 2004 May; 16(5):635-42. PubMed ID: 15096491 [TBL] [Abstract][Full Text] [Related]
4. Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity, by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire. Li Pira G; Bottone L; Ivaldi F; Tagliamacco A; Fiordoro S; Ricciardi A; Barbano G; Manca F J Infect Dis; 2005 Jan; 191(2):215-26. PubMed ID: 15609231 [TBL] [Abstract][Full Text] [Related]
5. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses. Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490 [TBL] [Abstract][Full Text] [Related]
6. Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes. Watanabe N; Kamachi Y; Koyama N; Hama A; Liang J; Nakamura Y; Yamamoto T; Isomura M; Kudo K; Kuzushima K; Kojima S Cytotherapy; 2004; 6(5):514-22. PubMed ID: 15512918 [TBL] [Abstract][Full Text] [Related]
7. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells. Forsberg O; Carlsson B; Tötterman TH; Essand M Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565 [TBL] [Abstract][Full Text] [Related]
8. Rapid generation of CMV pp65-specific T cells for immunotherapy. Bao L; Sun Q; Lucas KG J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296 [TBL] [Abstract][Full Text] [Related]
9. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC. Ramadan G; Konings S; Kurup VP; Keever-Taylor CA Cytotherapy; 2004; 6(3):223-34. PubMed ID: 15203979 [TBL] [Abstract][Full Text] [Related]
10. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming. Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545 [TBL] [Abstract][Full Text] [Related]
11. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara. La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596 [TBL] [Abstract][Full Text] [Related]
12. Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells. Paine A; Oelke M; Blasczyk R; Eiz-Vesper B Transfusion; 2007 Nov; 47(11):2143-52. PubMed ID: 17958544 [TBL] [Abstract][Full Text] [Related]
13. Immunostimulation by cytomegalovirus (CMV): helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors. Yachie A; Tosato G; Straus SE; Blaese RM J Immunol; 1985 Aug; 135(2):1395-400. PubMed ID: 2409150 [TBL] [Abstract][Full Text] [Related]
14. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA; J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038 [TBL] [Abstract][Full Text] [Related]
15. In vitro selection of HIV and CMV specific T-lymphocytes. Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225 [TBL] [Abstract][Full Text] [Related]
16. Recognition of CMV pp65 protein antigen by human CD4 T-cell lines induced with an immunodominant peptide pool. Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Bracci L; Lozzi L; Scarso L; Tripodi G; Manca F Hum Immunol; 2004 May; 65(5):537-43. PubMed ID: 15172454 [TBL] [Abstract][Full Text] [Related]
17. Clonal predominance of cytomegalovirus-specific CD8+ cytotoxic T lymphocytes in bone marrow recipients. Dolstra H; Van de Wiel-van Kemenade E; De Witte T; Preijers F Bone Marrow Transplant; 1996 Aug; 18(2):339-45. PubMed ID: 8864444 [TBL] [Abstract][Full Text] [Related]
19. Functional re-expression of CCR7 on CMV-specific CD8+ T cells upon antigenic stimulation. van Leeuwen EM; van Buul JD; Remmerswaal EB; Hordijk PL; ten Berge IJ; van Lier RA Int Immunol; 2005 Jun; 17(6):713-9. PubMed ID: 15837711 [TBL] [Abstract][Full Text] [Related]
20. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]